Paper Details
- Home
- Paper Details
The risks of medical treatment of prolactinoma.
Author: AlbarelFrederique, AmodruVincent, BrueThierry, CastinettiFrederic, CunyThomas, DufourHenry, GraillonThomas, MorangeIsabelle
Original Abstract of the Article :
First-line treatment of prolactinoma is usually medical, based on dopamine agonists receptors, mainly cabergoline. The classical side-effects of cabergoline (low blood pressure and nausea) have been well known since it was first introduced. Other side-effects, however, are more controversial or simp...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1016/j.ando.2020.12.008
データ提供：米国国立医学図書館（NLM）
The Risks of Medical Treatment for Prolactinoma: A Camel's Journey Through the Desert of Endocrine Health
The field of endocrinology is a vast and intricate desert, where researchers strive to understand the delicate balance of hormones and their impact on health. This study delves into the complexities of prolactinoma, a benign tumor of the pituitary gland that produces excess prolactin. The authors focus on the risks associated with medical treatment for prolactinoma, particularly the use of dopamine agonists like cabergoline. This comprehensive review provides valuable insights into the potential side effects of this commonly used medication, guiding clinicians toward more informed treatment decisions.
Navigating the Desert of Side Effects
The review highlights a range of potential side effects associated with cabergoline, including cardiac valvular fibrosis, pleural, pericardial, and retroperitoneal fibrosis, addictive/compulsive behaviors, and risks secondary to tumor shrinkage. These findings underscore the importance of careful monitoring and early intervention to mitigate potential risks. It's like navigating a desert where unexpected dangers can lurk beneath the surface, requiring vigilance and a well-equipped guide.
Maintaining Endocrine Health
This review provides valuable insights into the potential risks associated with medical treatment for prolactinoma. The study's findings emphasize the need for careful monitoring and early intervention to mitigate potential side effects. As researchers continue to explore the vast desert of endocrine health, this review serves as a valuable guide for navigating the complexities of prolactinoma treatment, ensuring that patients receive safe and effective care.
Dr. Camel's Conclusion
This review highlights the potential risks associated with medical treatment for prolactinoma, emphasizing the need for careful monitoring and early intervention to mitigate potential side effects. While cabergoline remains an important tool for managing this condition, it's crucial to be aware of its potential drawbacks and to weigh the risks and benefits of treatment. This research serves as a valuable reminder to approach all medical interventions with caution, always seeking to balance therapeutic benefits with potential risks.
Date :
- Date Completed 2021-10-26
- Date Revised 2021-10-26
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.